Calidi Biotherapeutics, Inc.

CLDICIK 0001855485 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 27, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewriteFull-doc fallback

Full filing:tone -0.0137Δ-0.000584% similar+718/-880 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 29, 20261.01 · Entry into a Material Definitive Agreeme3.02 · Unregistered Sales9.01 · Financial Statements and Exhibits May 14, 2026no items parsed May 8, 2026no items parsed Apr 2, 2026no items parsed Mar 27, 2026no items parsed

YoY shift: Neutral

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.05pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Calidi Biotherapeutics, Inc.

Name	Roles	Filings
Schoeneck James A	Director	8
Leftwich Scott	Director	7
Stewart Alan R.	Director	6
Camaisa Allan	OfficerDirector10% Owner	5
Jackson Andrew C.	Officer	3

Showing 1-5 of 18

Per pagePage 1 of 4Next

All filings

44 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jul 15, 2025	Schoeneck James A Director	Holdings only	-	-	-
Jul 15, 2025	Stewart Alan R. Director	Holdings only	-	-	-
Apr 25, 2025	Poma Eric E Chief Executive Officer · Director	Holdings only	-	-	-
Jan 3, 2025	Leftwich Scott Director	AGrant	11,684	-	-
Jan 3, 2025	Stewart Alan R. Director	AGrant	12,771	-	-

Showing 11-15 of 44

Per pagePrevPage 3 of 9Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value